Michael Frankel Selected Research

Therapeutics

1/2019	The Effect of Goal-Directed Therapy on Patient Morbidity and Mortality After Traumatic Brain Injury: Results From the Progesterone for the Treatment of Traumatic Brain Injury III Clinical Trial.
1/2018	Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke: Clinical Outcomes from a Phase I Safety Study.
11/2017	Utilization of a Smartphone Platform for Electronic Informed Consent in Acute Stroke Trials.
9/2016	Clopidogrel plus Aspirin for Symptomatic Intracranial Atherosclerotic Stenosis: A Pilot Study.
1/2016	Endovascular Therapy for Large Vessel Stroke in the Elderly: Hope in the New Stroke Era.
12/2015	Endovascular Treatment for Acute Ischemic Stroke in the Setting of Anticoagulation.
11/2015	Pittsburgh Response to Endovascular therapy (PRE) score: optimizing patient selection for endovascular therapy for large vessel occlusion strokes.
6/2015	Sulcal effacement with preserved gray-white junction: a sign of reversible ischemia.
8/2014	Pittsburgh outcomes after stroke thrombectomy score predicts outcomes after endovascular therapy for anterior circulation large vessel occlusions.
5/2013	Remote assessment of stroke using the iPhone 4.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Frankel Research Topics

Disease

26	Stroke (Strokes) 12/2021 - 03/2004
12	Ischemic Stroke 01/2023 - 07/2003
5	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 04/2007
3	Hypertension (High Blood Pressure) 08/2021 - 09/2016
3	Hemorrhage 02/2021 - 12/2015
3	Atrial Fibrillation 05/2017 - 12/2015
2	COVID-19 01/2023 - 12/2021
2	Hematoma 12/2015 - 12/2015
2	Deglutition Disorders (Dysphagia) 12/2010 - 12/2006
1	Myocardial Infarction 01/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2021
1	Brain Injuries (Brain Injury) 10/2019
1	Cerebral Infarction 10/2017
1	Aphasia (Dysphasia) 10/2017
1	Pathologic Constriction (Stenosis) 09/2016
1	Infarction (Infarctions) 01/2016
1	Cerebral Hemorrhage 12/2015
1	Phlebitis 12/2014
1	Thrombophlebitis 12/2014
1	Venous Thrombosis (Deep-Vein Thrombosis) 12/2010

Drug/Important Bio-Agent (IBA)

12	Tissue Plasminogen Activator (Alteplase)FDA Link 02/2021 - 03/2004
5	Progesterone FDA LinkGeneric 01/2021 - 04/2007
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2010
3	Cytidine Triphosphate (CTP)IBA 11/2021 - 01/2016
3	LipidsIBA 08/2021 - 12/2006
2	Proteins (Proteins, Gene)FDA Link 04/2014 - 07/2003
1	oxidized low density lipoproteinIBA 08/2021
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 02/2021
1	TicagrelorIBA 02/2021
1	SpectrinIBA 01/2021
1	dicesium N-succinimidyl 3- (undecahydrododecaboranyldithio)propionateIBA 01/2021
1	Calcium-Binding ProteinsIBA 01/2021
1	Glial Fibrillary Acidic ProteinIBA 01/2021
1	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2018
1	Blood Group Antigens (Blood Groups)IBA 01/2018
1	CholesterolIBA 05/2017
1	Clopidogrel (Plavix)FDA Link 09/2016
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2016
1	Anticonvulsants (Antiepileptic Drugs)IBA 12/2015
1	ProteomeIBA 04/2014
1	SolutionsIBA 05/2013
1	AnticoagulantsIBA 12/2010
1	Fibrinogen (Factor I)FDA Link 01/2010
1	Indicators and Reagents (Reagents)IBA 12/2006
1	hydroxide ionIBA 12/2006
1	Hemostatics (Antihemorrhagics)IBA 07/2003

Therapy/Procedure

10	Therapeutics 01/2019 - 05/2013
6	Thrombectomy 01/2023 - 08/2014
2	Time-to-Treatment 10/2016 - 04/2016
2	Punctures 01/2016 - 01/2016
1	Percutaneous Coronary Intervention 01/2023
1	Mechanical Thrombolysis 01/2023
1	Secondary Prevention 02/2021
1	CARE protocol 11/2018
1	Stents 09/2016
1	Length of Stay 04/2016
1	Contraindications 12/2015
1	Craniotomy 12/2015
1	Thrombolytic Therapy 01/2010